Valuation — not yet established
No valuation for US Kidney Research is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($14.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for US Kidney Research
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Seed Round | $475K | ▮ | ▮ |
| Oct 2022 | Seed Round | $1.5M | ▮ | ▮ |
| Sep 2020 | Seed Round | $320K | ▮ | ▮ |
| Feb 2020 | Seed Round | $500K | ▮ | ▮ |
How US Kidney Research's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For US Kidney Research, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has US Kidney Research raised?
- US Kidney Research has raised $14.0M in total funding across 4 recorded rounds.
- When did US Kidney Research last raise?
- US Kidney Research last raised in Sep 2024 (Seed Round), raising $475K.